KIFFIK Biomedical announced today the successful close of its Series A financing, completed ahead of schedule and ...

In this interview, Dr. Denise Heaney discusses how molecular diagnostics are reshaping antimicrobial stewardship and ...

Precise tumor diagnosis and treatment require the support of abundant molecular information. However, conventional molecular ...

A research team led by Senior Researcher Chanyong Park, Principal Researcher Dongkyu Lee, and Postdoctoral Researcher Changha ...

Next-gen diagnostics: Advances in molecular platforms, informatics and AI enable smarter, more personalized care. Innovation at scale: R&D strategies are shaping diagnostics to meet global healthcare ...

Korea's first fully automated diagnostic system capable of simultaneously detecting 16 major foodborne pathogens within one ...

Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform ...

Innovation in biotech is quickly becoming one of the most important drivers of U.S. competitiveness. As artificial ...

Fulgent Genetics ( ($FLGT) ) has shared an update. On December 20, 2025, Fulgent Genetics’ subsidiary Inform Diagnostics signed agreements to buy ...

Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular ...

Antibiotic resistance is one of the most pressing—and quietly advancing—challenges facing modern medicine. Among the most ...

Nearly 100 scientists, young researchers, doctoral candidates and students from 14 countries have gathered for the International Conference on Molecular Diagnostics in Microbiology and Diseases, organ ...